'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says

US guidances will be shorter and use a series of bullet points to communicate key ideas, replacing the current longer and wordier format.

FDA entrance sign 2016

FDA is embracing the short bulleted list to communicate its thinking about drug development going forward.

Rather than continue issuing guidances that are riddled with legalese, long paragraphs and sometimes extensive footnotes, going forward the documents...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership